Vesicare and Pegasys drug interactions - a phase IV clinical study of FDA data
Summary:
Drug interactions are reported among people who take Vesicare (solifenacin succinate) and Pegasys (peginterferon alfa 2a). Common drug interactions include anaemia among females and aplastic anaemia among males.
The phase IV clinical study analyzes what interactions people have when they take Vesicare and Pegasys. It is created by eHealthMe based on reports of 21 people who take the same drugs from the FDA, and is updated regularly.
What is Vesicare?
Vesicare has active ingredients of solifenacin succinate. It is often used in urge incontinence. eHealthMe is studying from 30,656 Vesicare users. Check the latest studies of Vesicare.
What is Pegasys?
Pegasys has active ingredients of peginterferon alfa 2a. It is often used in hepatitis c. eHealthMe is studying from 57,446 Pegasys users. Check the latest studies of Pegasys.
21 people who take Vesicare and Pegasys together, and have interactions are studied.

What are the common drug interactions of Vesicare and Pegasys, by gender? *:
female:
- Anaemia (lack of blood)
- Nausea (feeling of having an urge to vomit)
- Cellulitis (infection under the skin)
- Constipation
- Dyspepsia (indigestion)
- Fatigue (feeling of tiredness)
- Gastrointestinal haemorrhage (bleeding gastrointestinal tract)
- Headache (pain in head)
- Hepatic cirrhosis (chronic liver disease characterized by replacement of liver tissue by fibrosis, scar tissue)
- Hyperthermia (body temperature greatly above normal)
male:
- Aplastic anaemia (blood disorder in which the body's bone marrow doesn't make enough new blood cells)
- Pancytopenia (medical condition in which there is a reduction in the number of red and white blood cells, as well as platelets)
- Depressed mood
- Drug ineffective
- Dry mouth
- Dysgeusia (disorder of the sense of taste)
- Dyspnoea (difficult or laboured respiration)
- Fatigue (feeling of tiredness)
- Frequent bowel movements
- Haemorrhoids (a swollen vein or group of veins in the region of the anus)
What are the common drug interactions of Vesicare and Pegasys, by age (0-1 to 60+)? *:
0-1:
n/a
2-9:
n/a
10-19:
n/a
20-29:
n/a
30-39:
- Aplastic anaemia (blood disorder in which the body's bone marrow doesn't make enough new blood cells)
- Pancytopenia (medical condition in which there is a reduction in the number of red and white blood cells, as well as platelets)
- Thrombocytopenia (decrease of platelets in blood)
- Depressed mood
- Suicidal ideation
40-49:
- Anaemia (lack of blood)
- Death
- Drug ineffective
- Dysgeusia (disorder of the sense of taste)
- Neutropenia (an abnormally low number of neutrophils)
- Sputum increased
- White blood cell count increased
50-59:
- Thrombocytopenia (decrease of platelets in blood)
- Anaemia (lack of blood)
- Aplastic anaemia (blood disorder in which the body's bone marrow doesn't make enough new blood cells)
- Cellulitis (infection under the skin)
- Gastrointestinal haemorrhage (bleeding gastrointestinal tract)
- Hepatic cirrhosis (chronic liver disease characterized by replacement of liver tissue by fibrosis, scar tissue)
- Hyperthermia (body temperature greatly above normal)
- Nausea (feeling of having an urge to vomit)
- Pancytopenia (medical condition in which there is a reduction in the number of red and white blood cells, as well as platelets)
- Peritonitis (inflammation of the peritoneum, the thin tissue that lines the inner wall of the abdomen and covers most of the abdominal organs)
60+:
- Anaemia (lack of blood)
- Anorectal discomfort
- Fatigue (feeling of tiredness)
- Frequent bowel movements
- Haemorrhoids (a swollen vein or group of veins in the region of the anus)
- Influenza like illness
- Nail bed inflammation (infection of nail bed)
- Nasopharyngitis (inflammation of the nasopharynx)
- Onychalgia (nail biting)
- Pruritus (severe itching of the skin)
What are the existing conditions these people have? *
- High Blood Pressure: 7 people, 33.33%
- Urinary Incontinence (inability to control the flow of urine and involuntary urination): 3 people, 14.29%
- Nausea (feeling of having an urge to vomit): 3 people, 14.29%
- Muscle Spasms (muscle contraction): 3 people, 14.29%
- Insomnia (sleeplessness): 3 people, 14.29%
- Depression: 3 people, 14.29%
- Neuralgia (pain in one or more nerves): 2 people, 9.52%
- Narcolepsy (brain's inability to regulate sleep-wake cycles normally): 2 people, 9.52%
- Cataplexy (loss of muscle tone accompanied by full conscious awareness): 2 people, 9.52%
* Approximation only. Some reports may have incomplete information.
Do you take Vesicare and Pegasys?
- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously
Related studies:
Effectiveness of, side effects of, and alternative drugs to the 2 drugs:
Browse all drug interactions of Vesicare and Pegasys:
a b c d e f g h i j k l m n o p q r s t u v w x y zSub-studies by gender and age:
Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Browse all side effects of Vesicare:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all side effects of Pegasys:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all interactions between Vesicare and drugs from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all interactions between Pegasys and drugs from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zHow the study uses the data?
The study uses data from the FDA. It is based on solifenacin succinate and peginterferon alfa 2a (the active ingredients of Vesicare and Pegasys, respectively), and Vesicare and Pegasys (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
How to use the study?
DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.
Who is eHealthMe?
With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Could Levaquin cause Swallowing Pain Or Burning? - now
- Could Mobic cause Herniated Nucleus Pulposus (Slipped Disk)? - 2 seconds ago
- Could Levaquin cause Pain In Limb? - 6 seconds ago
- Could Duoneb cause Swallowing Difficulty? - 10 seconds ago
- Could Brintellix cause Asthma? - 11 seconds ago
- Drug interactions of Levothroid and Furosemide - 17 seconds ago
- Could Augmentin cause Multiple Myeloma? - 17 seconds ago
- Could Manganese cause Back Pain? - 19 seconds ago
- Could Augmentin cause Oropharyngeal Blistering? - 22 seconds ago
- Drug interactions of Florinef and Pepcid - 27 seconds ago